Obermatt

Compare · head to head

Alfresa Holdings vs Rohto Pharmaceutical

Rohto Pharmaceutical ranks higher overall — 360 rank 81 vs 70.

Alfresa Holdings leads on Value (82 vs 59) and Safety (68 vs 61). Rohto Pharmaceutical leads on Quality (52 vs 33) and Growth (56 vs 36). The two are close on Sentiment.

Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.

Compare
Profile
CountryJapanJapan
SectorHealth CareHome & Consumer Goods
IndustryHealth Care Providers & ServicesPersonal Products
SizeX-LargeLarge
ISINJP3126340003JP3982400008
Last update2026-04-022026-04-02
History
360 (V1) since 2023
Ranks
3607081
Value8259
Quality3352
Growth3656
Safety6861
Sentiment5155
Quality details
Profitability3951
Cash Truth2654

Full analyses: Alfresa Holdings · Rohto Pharmaceutical

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →